LymphoVista
ctDNA sequencing in-house IVD for lymphoma genotyping, MRD assessment and longitudinal monitoring.
- Developer
- LIQOMICS
- Intended use
- Monitoring, Mrd
- Cancer scope
- B-cell lymphoma, Hodgkin lymphoma
- Specimen
- Peripheral whole blood
- Molecular modality
- DNA mutation
- Current version
- LymphoVista current family (B-cell lymphoma / Hodgkin lymphoma, 2026)
- Evidence context
- 1 structured studies · 0 indexed performance results · 3 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.